Biopharmaceutical Market Share by Manufacturers, Types and Current Scenario 2017-2022

****** Biopharmaceutical Market is segmented on the basis of type, therapeutic applications and geography. Biopharmaceuticals come across as medicinal drugs produced by isolating the medicinal products from biological sources such as from humans, plants, animals, and microorganisms by making use of biotechnological techniques such as recombinant DNA technology.

Access Biopharmaceutical Market Report with TOC @

They could also be produced using transgenic organisms, especially plants and animals that are genetically engineered for producing drugs. These drugs help in preventing and treating various diseases such as psoriatic arthritis, rheumatoid arthritis, anemia arising from chemotherapy, psoriasis, and cardiovascular disease, diabetes and cancer, and chronic renal failure. Since biopharmaceuticals are capable of technically modulating any physiological pathway that has been completely comprehended, their use is continuously increasing.

This coupled with the ability of biopharmaceuticals to treat diseases previously not treatable, has resulted in a huge market demand, which, in turn, has increased the profit margins for manufacturers. Factors such as cumbersome and complicated regulatory requirements, high-end manufacturing requirements, and constantly increasing demand for affordable biopharmaceuticals are hampering the market growth.

At present, the biopharmaceutical market has great opportunities for both – existing players and novel market entrants. The patents with regards to several biopharmaceuticals are getting expired in the next five years and this is bound to create an opportunity for biosimilars manufacturers. Similarly, no company has yet found a way to effectively lessen the cost of biosimilars and there is a huge market opportunity for any company that could solve this problem.

Despite several growth factors driving the biopharmaceutical market, it faces severe challenges to be overcome for tapping the full potential of the biopharmaceutical market. One such factor is the need for cold storage for almost every biopharmaceutical. This limits their reach in the developing as well as third world countries. In addition, the process to develop a biopharmaceutical is also difficult, as it involves living biological systems. North America holds the largest market share for biopharmaceuticals. This could be attributed to technological advancements in the region. By types, monoclonal antibodies are the fastest growing segment. By therapeutic application, oncology is the largest segment in the biopharmaceuticals market. Biopharmaceuticals have broad applications in the pharmaceutical industry.

On the basis of type, the biopharmaceutical market is segmented into erythropoietin, monoclonal antibodies, granulocyte-colony stimulating factor (G-CSF), putrefied proteins, recombinant proteins, recombinant human insulin, interferon, growth hormones, and vaccines and so on. On the basis of therapeutic applications, the biopharmaceutical market is segmented into metabolic disorders, oncology, neurological disorders, cardiovascular diseases, inflammatory and infectious deseases, autoimmune disorders, hormonal disorders, disease prevention and so on.

Top Key Players Analysis covered in Biopharmaceutical Market Report

  • Roche
  • Amgen
  • AbbVie
  • Sanofi-Aventis
  • Johnson & Johnson
  • Pfizer
  • Novo Nordisk
  • Eli Lilly
  • Novartis
  • Merck


Segmentation on the basis of Product Types,

  • Monoclonal Antibodies
  • Interferon
  • Colony-Stimulating Factor
  • Erythropoietin
  • Insulin
  • Vaccines
  • Growth Hormones
  • Other


Segmentation on the basis of Applications/End-Users,

  • Tumor
  • Diabetes
  • Cardiovascular
  • Hemophilia
  • Other


Request a Sample Copy of Biopharmaceutical Market Report @


Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Biopharmaceuticals in these regions, from 2012 to 2022 (forecast), covering

  • North America
  • Europe
  • China
  • Japan
  • Southeast Asia
  • India


Visit Our Blog @


Get in touch

At Million Insights, we work with the aim to reach the highest levels of customer satisfaction. Our representatives strive to understand diverse client requirements and cater to the same with the most innovative and functional solutions.


Contact Person:

Ryan Manuel

Research Support Specialist, USA



Million Insights

Office No. 302, 3rd Floor, Manikchand Galleria,

Model Colony, Shivaji Nagar, Pune, MH, 411016 India

Phone: 91-20-65300184


Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.